Light-Responsive Delivery Nanoplatforms in Cancer Theranostics

Atul Garkal; Anam Sami; Jahanvi Patel; Lajja Patel; Namdev L. Dhas; Tejal Mehta

doi:10.1201/9781003368731-10

Light-Responsive Delivery Nanoplatforms in Cancer Theranostics

Atul Garkal
, Anam Sami
, Jahanvi Patel
, Lajja Patel
, Namdev L. Dhas
, Tejal Mehta

Research output: Chapter in Book/Report/Conference proceeding › Chapter

3 Citations (Scopus)

Abstract

Cancer is the second leading cause of death worldwide, accounting for a predictable 9.6 million patient losses, or one in six deaths. In men, lung, liver, colorectal, prostate, and stomach cancer are the most common types of cancer, while in women, breast, lung, colorectal, thyroid, and cervical cancer are the most common. In recent eras, stimuli-responsive drug delivery systems play an important role in the diagnosis and treatment of these diseases. Light-responsive therapeutics have been developed as potential therapies for disease management. Photo-triggered formulations in combination with chemotherapy will be promising in the future for cancer treatment, and some of the formulations have already reached clinical trials. This chapter summarizes the different light-sensitive therapies for cancer diagnosis and treatment and their applications with mechanisms.

Original language	English
Title of host publication	Site-specific Cancer Nanotheranostics
Subtitle of host publication	A Microenvironment-responsive Approach
Publisher	CRC Press/Balkema
Pages	155-169
Number of pages	15
ISBN (Electronic)	9781000960051
ISBN (Print)	9781032434827
DOIs	https://doi.org/10.1201/9781003368731-10
Publication status	Published - 01-01-2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

General Engineering
General Medicine
Pharmacology, Toxicology and Pharmaceutics(all)

Access to Document

10.1201/9781003368731-10

Cite this

@inbook{7b2e294ac9d341bf8e45cc2d3c08be7a,

title = "Light-Responsive Delivery Nanoplatforms in Cancer Theranostics",

abstract = "Cancer is the second leading cause of death worldwide, accounting for a predictable 9.6 million patient losses, or one in six deaths. In men, lung, liver, colorectal, prostate, and stomach cancer are the most common types of cancer, while in women, breast, lung, colorectal, thyroid, and cervical cancer are the most common. In recent eras, stimuli-responsive drug delivery systems play an important role in the diagnosis and treatment of these diseases. Light-responsive therapeutics have been developed as potential therapies for disease management. Photo-triggered formulations in combination with chemotherapy will be promising in the future for cancer treatment, and some of the formulations have already reached clinical trials. This chapter summarizes the different light-sensitive therapies for cancer diagnosis and treatment and their applications with mechanisms.",

author = "Atul Garkal and Anam Sami and Jahanvi Patel and Lajja Patel and Dhas, \{Namdev L.\} and Tejal Mehta",

note = "Publisher Copyright: {\textcopyright} 2024 selection and editorial matter, Yashwant V. Pathak, Jayvadan K. Patel, Namdev L. Dhas and Vipul P. Patel; individual chapters, the contributors.",

year = "2023",

month = jan,

day = "1",

doi = "10.1201/9781003368731-10",

language = "English",

isbn = "9781032434827",

pages = "155--169",

booktitle = "Site-specific Cancer Nanotheranostics",

publisher = "CRC Press/Balkema",

}

TY - CHAP

T1 - Light-Responsive Delivery Nanoplatforms in Cancer Theranostics

AU - Garkal, Atul

AU - Sami, Anam

AU - Patel, Jahanvi

AU - Patel, Lajja

AU - Dhas, Namdev L.

AU - Mehta, Tejal

PY - 2023/1/1

Y1 - 2023/1/1

N2 - Cancer is the second leading cause of death worldwide, accounting for a predictable 9.6 million patient losses, or one in six deaths. In men, lung, liver, colorectal, prostate, and stomach cancer are the most common types of cancer, while in women, breast, lung, colorectal, thyroid, and cervical cancer are the most common. In recent eras, stimuli-responsive drug delivery systems play an important role in the diagnosis and treatment of these diseases. Light-responsive therapeutics have been developed as potential therapies for disease management. Photo-triggered formulations in combination with chemotherapy will be promising in the future for cancer treatment, and some of the formulations have already reached clinical trials. This chapter summarizes the different light-sensitive therapies for cancer diagnosis and treatment and their applications with mechanisms.

AB - Cancer is the second leading cause of death worldwide, accounting for a predictable 9.6 million patient losses, or one in six deaths. In men, lung, liver, colorectal, prostate, and stomach cancer are the most common types of cancer, while in women, breast, lung, colorectal, thyroid, and cervical cancer are the most common. In recent eras, stimuli-responsive drug delivery systems play an important role in the diagnosis and treatment of these diseases. Light-responsive therapeutics have been developed as potential therapies for disease management. Photo-triggered formulations in combination with chemotherapy will be promising in the future for cancer treatment, and some of the formulations have already reached clinical trials. This chapter summarizes the different light-sensitive therapies for cancer diagnosis and treatment and their applications with mechanisms.

UR - https://www.scopus.com/pages/publications/85173886539

UR - https://www.scopus.com/pages/publications/85173886539#tab=citedBy

U2 - 10.1201/9781003368731-10

DO - 10.1201/9781003368731-10

M3 - Chapter

AN - SCOPUS:85173886539

SN - 9781032434827

SP - 155

EP - 169

BT - Site-specific Cancer Nanotheranostics

PB - CRC Press/Balkema

ER -

Light-Responsive Delivery Nanoplatforms in Cancer Theranostics

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this